JUNE 2025
Terms of Service
Subscribe to Updates?
QUICK LINKS:
PLEASE READ THIS AGREEMENT CAREFULLY BEFORE USING THIS SERVICE.
BY USING THE SERVICES OR CLICKING “AGREE” IN THE ORDER PLACED BY CUSTOMER, CUSTOMER IS AGREEING TO BE BOUND BY THIS AGREEMENT, WHICH SETS FORTH RXNT’S TERMS OF SERVICE. ANY ORDER PLACED BY A CUSTOMER SHALL CONSTITUTE AN OFFER TO CONTRACT SUBJECT TO THE STANDARD TERMS AND CONDITIONS HEREIN CONTAINED AND, UNLESS EXPRESSLY AGREED IN WRITING BY AN AUTHORIZED REPRESENTATIVE OF RXNT, NO ADDITION TO, OR VARIATION FROM, THESE STANDARD TERMS AND CONDITIONS SHALL APPLY. THESE STANDARD TERMS AND CONDITIONS WILL NEGATE THE CUSTOMER’S OWN TERMS AND CONDITIONS AS SUCH.
IF CUSTOMER IS AGREEING TO THIS AGREEMENT ON BEHALF OF OR FOR THE BENEFIT OF THEIR EMPLOYER, THEN CUSTOMER REPRESENTS AND WARRANTS THAT THEY HAVE THE NECESSARY AUTHORITY TO AGREE TO THIS AGREEMENT ON THEIR EMPLOYER’S BEHALF.
This agreement (Agreement) is between Networking Technology, Inc. d/b/a RXNT (RXNT), a Maryland corporation, and the customer agreeing to these terms (“Customer”), and covers all services provided by RXNT to Customer. Customer understands that use of the Services is also governed by the Subscription Summary between the parties, RXNT’s Support Policy (Attachment A), its Pricing Policy (Attachment B), its Third Party Terms (Attachment C), its Business Associate Agreement (Attachment D), its Privacy Policy (Attachment E), its Security Notice (Attachment F), its Return of Data FAQ (Attachment G), and its Service Level FAQ (Attachment H), each of which is incorporated by reference into the Agreement and each of which may be modified from time to time.
1) RXNT SOFTWARE SERVICES
This Agreement provides Customer and Customer’s Authorized Users (defined below) access and use of RXNT’s cloud-based solutions subscription services, as specified on the electronic or written order between the parties (Subscription Summary), which is incorporated by reference into this Agreement and made part of it. Customer may purchase and utilize RXNT PM (Practice Management), RXNT EHR (electronic health records), RXNT ERX (electronic prescribing), Ambient IQ, and RXnotify, and related services under this Agreement (Services).
2) AUTHORIZED USERS
Customer’s employees and contractors who use the Services are referred to herein as “Authorized Users.” Customer is fully responsible for all activities and use or misuse of the Services by any Authorized Users. Customer is also responsible for ensuring that Authorized Users comply with the Agreement. We have the right to disable Customer and Authorized Users’ use of the Services at any time for any reason, including if, in our sole discretion, we believe that there has been a failure to comply with this Agreement.
3) REGULATORY COMPLIANCE
The Services are intended for use in environments subject to health and data privacy regulations, including the Health Insurance Portability and Accountability Act of 1996 (HIPAA). Customer and Authorized Users remain responsible for ensuring the use of the Services complies with all applicable laws and regulatory requirements, including HIPAA.
4) USE OF SERVICES
a. RXNT Responsibilities
Training. RXNT shall provide online training to Customer and Authorized Users during the Standard Onboarding Period (defined in Attachment B) for the Service(s) Customer has subscribed to. All Authorized Users must complete online training before Authorized Users being granted access to RXNT ERX solution.
Support. RXNT shall provide customer support for the Services as further detailed in the RXNT Support Policy. Customer and Authorized Users shall be responsible for their own devices, systems, applications, connections, and software used to access the Services.
b. Customer Responsibilities
Identity Proofing. Customer and Authorized Users will be required to complete identity proofing to the IAL2 standard or greater before gaining access to the Services. Identity proofing is completed through a third-party vendor of our choosing.
Customer must use Form I-9 to verify the identity and employment authorization of all Authorized Users, and must be able to provide evidence of such upon RXNT request. Customer and Authorized Users agree that they (i) will not share their registration login credentials or give their login credentials to anyone else, (ii) are responsible for maintaining the confidentiality of their password, and (iii) agree to accept responsibility for all activities that occur under their account or password.
Accuracy of Information Provided by Customer. Customer and Authorized Users represent and warrant to RXNT that all Customer Information and other material provided under Customer’s account, by Customer or on its behalf, is true, correct, and accurate. If Customer learns that any Customer Information provided to RXNT as part of the Services is not true, correct, or accurate, Customer must immediately notify RXNT by phone and in writing of this fact, and provide the true, correct, and accurate information to RXNT. RXNT relies on Customer representations regarding the truth, accuracy, and compliance with the laws of Customer Information. RXNT IS NOT LIABLE FOR ANY LOSS OR DAMAGE CAUSED BY CUSTOMER’S FAILURE TO COMPLY WITH THIS PARAGRAPH, IRRESPECTIVE OF ANY ACT OR OMISSION ON THE PART OF RXNT.
Electronic Prescriptions for Controlled Substances. If Customer uses the Services for Electronic Prescriptions for Controlled Substances (Electronic Prescription), the following applies:
- Tokens. Each Electronic Prescription account is assigned to a specific provider (Prescribing Provider) authorized by Customer. Each Prescribing Provider will be provided a soft token by a third-party (Soft Token). Soft Tokens are referred to generally as a Token.
- Live ID. Prescribing Providers using the RXNT ERX mobile application must authenticate by using Live ID. Live ID is conducted by a third-party.
- Customer Responsibilities. Customer and each Prescribing Provider agrees: (a) that each Prescribing Provider may not allow any other person to use the Token or enter the login passphrase in order to sign controlled substance prescriptions; (b) that each Prescribing Provider is responsible for using their own biometrics when setting up two-factor authentication; (c) that failure to secure the Token, login passphrase, or any biometric information may provide a basis for revocation or suspension of the Electronic Prescription account; (d) if a Prescribing Provider’s Token has been compromised or stolen, Prescribing Provider is responsible for immediately revoking and deactivating the Token; (e) to notify RXNT within one business day of discovery if: (i) Customer or a Prescribing Provider is contacted by a pharmacy because one or more controlled substance prescriptions are displaying the incorrect United States Drug Enforcement Administration (DEA) number; (ii) if Customer or a Prescribing Provider discover that one or more controlled substance prescriptions issued using a Prescribing Provider DEA number were not consistent with the prescriptions actually signed, or were not signed at all; (iii) if a Prescribing Provider’s Token has been compromised, or the authentication protocol has been compromised in any way; (e) that the Prescribing Provider is responsible for any controlled substance prescriptions written using its two-factor authentication credential; (f) that Prescribing Providers have the same responsibilities when issuing electronic prescriptions for controlled substances as when issuing paper or oral prescriptions; (g) to prescribe controlled substances only for legitimate medical purposes; (h) to review security logs on a daily basis for any security incidents; and (i) to report to the DEA any security incident and provide RXNT with a copy of such report. Customer agrees to keep all security incident reports on file for two years.
Electronic Prescriptions (Excluding Prescriptions for Controlled Substances). If Customer uses the Services for Electronic Prescriptions (excluding prescriptions for controlled substances), the Customer and each Prescribing Provider agrees: (a) to only prescribe on their own behalf and not give away password or credentials to another person to prescribe for them; and (b) to take the same responsibility you would when transmitting paper or phone prescriptions. If an authorized individual is prescribing a prescription on behalf of a Provider (Prescribing Personnel), the Prescribing Personnel is responsible for using their own account accessed using their credentials.
Electronic Prescriptions in General. If Customer uses the Services for Electronic Prescriptions, Customer agrees to designate at least two (2) individuals to manage access control to the Electronic Prescription Services. The persons designated to manage access control to the Electronic Prescription Services are responsible for (i) verifying necessary information for all Prescribing Providers, and (ii) revoking or disabling a Prescribing Provider’s access when required. One of the designated individuals is the Prescribing Provider for EPCS.
Consents and Authorizations. Customer and Authorized Users are solely responsible for ensuring that all applicable consents, notices, and authorizations are obtained where required. Customer is also responsible for confirming that the use of the Services in Customer’s location and practice setting is lawful, compliant with institutional policies, and not prohibited by any applicable local, state, or federal laws.
c. Permitted and Prohibited Uses
Customer and Authorized Users agree to use the Services only for their intended purpose. Customer and Authorized Users may not: (i) sell, resell, rent or lease the Services, use the Services beyond their intended operations; (ii) use the Services to store or transmit infringing, unsolicited marketing messages, libelous, or otherwise unlawful or tortious material, or to store or transmit material in violation of third-party rights (including without limitation any privacy rights); (iii) interfere with or disrupt the integrity or performance of the Services; (iv) attempt to gain unauthorized access to the Services or its related systems or networks; (v) reverse engineer the Services or remove or modify any proprietary marking or restrictive legends in the Services ; (vi) use the Services in violation of any law, including without limitation, HIPAA, Telephone Consumer Protection Act, and any spam laws (including obtaining any legally required consents from all third parties (including its patients or customers) to send and receive any text message and/or emails using the Service and honoring any requests revoking such consent or otherwise “opting-out” of receiving any such messages and/or emails); (vii) access the Services to build a competitive product or service, or copy any feature, function or graphic of the Services for competitive purposes; (viii) introduce, post, or upload to the Services any virus, worm, “black door,” Trojan Horse, or similar harmful code; (ix) circumvent any processes, procedures, or technologies that we have put in place to safeguard the Services; or (x) save, store, or archive any portion of the Services (including, without limitation, any data contained therein) outside the Services.
d. Additional Terms
Reminders, Statements, and Other SMS Messages. Customer agrees that by registering for the Services, including any request forms or use of communications features, constitutes a request for RXNT to send email, fax, phone call, or SMS reminders about upcoming appointments, billing statements, multi-factor authentication (MFA), special offers, and upcoming events. RXNT is not responsible for any text messaging or data transmission fees. If Customer provides a cellular phone number, they agree to receive communications from RXNT, and Customer specifically authorizes RXNT to send text messages or calls to such number. Customer represents and warrants that it has the authority to grant such authorization.
Reviews & Opinions. By submitting a review, testimonial, patient testimonial, quote, or any other content (“Content Submission”) to RXNT, Customer grants RXNT a perpetual, worldwide, royalty-free, non-exclusive license to use, reproduce, modify, adapt, publish, translate, distribute, and display such Content Submission in any medium, including but not limited to RXNT social media, rxnt.com, rxnotify.com, and any other RXNT-operated website or landing page. This includes the right to use your name, likeness, testimonials, photos, and logo in connection with the Content Submission for promotional or marketing purposes, without further compensation or notification to Customer. Customer and Authorized Users warrant and represent that (i) they have the necessary rights and permissions to grant RXNT this license, (ii) the Content Submission Customer provides does not infringe upon the rights of any third party, and (iii) all patient testimonials submitted by Customer or Authorized Users are accurate and have the patient's consent and comply with ethical guidelines of professional medical associations as well as state and local medical and private practice boards and governing bodies.
RXNT does not endorse, validate as accurate, or necessarily agree with any of the reviews, links, and user-generated content from Customer, Authorized Users, or any other user on the Services. RXNT reserves the right to refuse to publish any patient review provided by Customer or Authorized Users.
Advertisements. RXNT reserves the right to place advertisements or messages from third parties in the Services. Such advertisements or messages from third parties may be visible to Authorized Users as well as Customer.
5) OWNERSHIP AND USE OF DATA
Customer Information. Customer retains full ownership of Customer Information. “Customer Information” includes (i) any personal information and data that Customer or Authorized Users submit to the Services, including name, email address, address, and other identifying information; (ii) any clinical information and data that you submit to the Services, including prescription information; and (iii) protected health information (“PHI”). Customer grants RXNT a non-exclusive, royalty-free license to modify, store, transmit, and otherwise use the Customer Information for purposes of RXNT performing under this Agreement. All PHI included in Customer Information will be processed following the Business Associate Agreement attached hereto as Attachment D (“BAA”). If the terms of this Agreement conflict with the terms of the BAA, the terms of the BAA shall control solely for the processing of PHI. By providing Customer Information, Customer and Authorized Users agree to be legally bound by the terms and conditions of the BAA, which is made part of this Agreement. Customer and Authorized Users represent and warrant to RXNT that (i) any Customer Information submitted to the Services does not violate any copyright, trade secret, privacy or other third-party right; and (ii) it will not submit any Customer Information that is untrue, defamatory, harmful to any person, or violates HIPAA Privacy Rules, State or Federal laws on patient privacy.
De-Identified and Aggregate Data. Under Sections II(b) and (c) of the BAA, RXNT has the right to de-identify all data received or generated under this Agreement in accordance with applicable law. Notwithstanding anything to the contrary herein, we may use Customer Information, as well as any data that we collect in connection with our monitoring of the performance of the Services and use by Customer, including, without limitation, date and time that Customer accesses the Services, the frequency and number of times such pages are accessed, the number of times the Services is used in a given period and other usage and performance data (“Usage Data”) that we may collect, in an anonymous and aggregated form (“Aggregate Data”) to operate, maintain, manage, and improve our products and services including the Services. Aggregate Data does not identify Customer or any individual. Customer hereby agrees that we may collect, use, publish, disseminate, sell, transfer, and otherwise exploit such Aggregate Data. All right, title, and interest in and to the Services, the Aggregate Data, the Usage Data, and the de-identified data, including all modifications, improvements, adaptations, enhancements, derivatives, or translations made thereto or therefrom, and all intellectual property rights therein, are and will remain the sole and exclusive property of RXNT.
6) PROPRIETARY RIGHTS
Services may contain all or some of the following material: software, text, graphics, images, sound recordings, audiovisual works, and other material provided by or on behalf of RXNT (“RXNT Content”). All right, title, and interest in and to the RXNT Content, including all associated intellectual property rights, remain only with RXNT. For the avoidance of doubt, RXNT Content shall not include Customer Information. RXNT Content may be owned by us or by third parties. Unauthorized use of the RXNT Content may violate copyright, trademark, and other laws. Customer has no rights in or to RXNT Content, and Customer will not use RXNT Content except as permitted under this Agreement. No other use is permitted without prior written consent from us. Customer must retain all proprietary notices contained in the original RXNT Content on any copy Customer makes of the RXNT Content. Customer may not sell, transfer, assign, license, sublicense, or modify the RXNT Content or reproduce, display, publicly perform, make a derivative version of, distribute, or otherwise use the RXNT Content in any way for any public or commercial purpose. The use or posting of the RXNT Content on any other website or in a networked computer environment for any purpose is expressly prohibited.
The trademarks, service marks, and logos of RXNT (the “RXNT Trademarks”) used and displayed on the Services are registered and unregistered trademarks or service marks of RXNT. Other company, product, and service names located on the Services may be trademarks or service marks owned by others (the “Third-Party Trademarks” and, collectively with RXNT Trademarks, the “Trademarks”). Nothing on the Platform should be construed as granting, by implication, estoppel, or otherwise, any license or right to use the Trademarks, without our prior written permission specific for each such use. Use of the Trademarks as part of a link to or from any website is prohibited unless establishment of such a link is approved in advance by us in writing. None of the RXNT Content may be retransmitted without our express, written consent for every instance.
7) PAYMENT TERMS
a. Access and Future Services
Certain aspects of the Services may be provided to Customers and Authorized Users at no cost. Please note that if any aspect of Services is provided at no cost, RXNT reserves the right to make those aspects of the existing Services, any updates, upgrades, new versions, or other products that incorporate those services (“Future Services”) available for a fee. Future Services may also be subject to other fees and/or agreements. Customer acknowledges that Customer is responsible for all fees and expenses related to accessing or using the Service, including internet service provider fees.
b. Payment
Customer must pay all fees as specified on any Subscription Summary, and must pay all fees for any additional services utilized, as specified in the Pricing Policy. All fees are due upon receipt. Customer is responsible for providing complete and accurate billing and contact information to RXNT and notifying RXNT of any changes to such information.
c. Credit Card and ACH
Customer must pay all fees (US$) with a credit card or via ACH put on file with RXNT (“Payment Source”). Customer hereby authorizes RXNT to charge such credit card or withdraw from Customer’s bank account via ACH for all purchased Services and related services, any renewals, and applicable monthly associated processing fees. Customer’s Payment Source will be charged immediately upon enrollment for the Services. For each renewal thereafter, Customer’s Payment Source will be charged after email notification by RXNT three (3) days prior to renewal (“Renewal Date”). An invoice and a receipt of payment are both available on the Renewal Date.
d. Taxes
RXNT’s fees do not include any taxes, levies, or other similar governmental assessments (Taxes). Customer is responsible for the payment of all Taxes associated with its purchases under this Agreement. RXNT is solely responsible for taxes assessable against RXNT based on its income, property, and employees.
e. Suspension of Service
RXNT may suspend or terminate the Services, or both, if Customer has not paid amounts owed to RXNT when due. In advance of any suspension or termination, RXNT will make commercially reasonable efforts to send a minimum 3-day notice of payment default to Customer before suspension or termination (Customer is responsible for updating its contact information with RXNT and notifying RXNT of any changes to such information).
f. Fee Changes
All retail pricing fees may be changed with 30 days’ advance email notice to Customer. Customer is responsible for keeping their updated email address on file with RXNT.
g. Discounts
Discounts may be provided to Customer at the sole discretion of RXNT. All discounts provided by RXNT will be based on the pricing detailed in the Pricing Policy.
h. Postage Fees
Since postage rate increases are publicly announced by the United States Postal Service, RXNT will automatically apply the rate increase to all services impacted by the change without advance notice.
8) REPRESENTATIONS AND WARRANTIES
Customer and Authorized Users represent and warrant that they: (i) have all rights and permissions necessary to provide us with or grant us access to and use of Customer Information, (ii) have obtained all necessary and appropriate consents, permissions, and authorizations in accordance with all applicable laws and regulations including but not limited to, obtaining consents from patients, their parents and/or legal guardians to send and receive text messages using the Services and honoring any requests revoking such consent or otherwise “opting-out” of receiving any such text messages; (iii) will maintain records of such consents for the period required by applicable laws and regulations. Upon our request, Customer shall provide copies of such consents to us.
9) SERVICE LEVEL AGREEMENT/DISCLAIMERS
a. Availability
RXNT will make commercially reasonable efforts to maintain uptime of 99%.
b. Mutual Compliance with Laws
Each party represents and warrants to the other party that it will comply with all applicable laws regarding its performance under this Agreement.
c. NO MEDICAL ADVICE PROVIDED BY RXNT
RXNT and the Services do not provide medical advice, provide medical advice, diagnostic services, or prescribe medication. Any outputs generated by the Service, including summaries, clinical insights, or suggested actions based on patient encounter data, are intended solely for informational support. Clinical decisions remain solely the responsibility of the licensed healthcare professional, who must independently assess and verify all information provided by the Service.
Use of the Services is not a substitute for the professional judgment of health care providers in diagnosing and treating patients. Customer and Authorized Users agree that they are solely responsible for verifying the accuracy of patient information (including, without limitation, obtaining all applicable patients' medical and medication history and allergies), obtaining patient’s consent to use the Services (including without limitation the patient portal portion of the Services and associated electronic communications consents), and for all of its decisions or actions with respect to the medical care, treatment, and well-being of its patients, including without limitation, all of Customer and Authorized Users’ acts or omissions. Any use or reliance by Customer and Authorized Users upon the Services will not diminish that responsibility. Customer and Authorized Users assume all risks associated with Customer and Authorized Users’ clinical use of the Services for the treatment of patients. Neither RXNT nor its licensors assume any liability or responsibility for damage or injury (including death) to Customer, Authorized Users, a patient, other person, or tangible property arising from any use of the Services.
d. CUSTOMER’S COMPLIANCE WITH MEDICAL RETENTION LAWS AND PATIENT RECORDS ACCESS LAWS
Customer and Authorized Users are responsible for understanding and complying with all state and federal laws related to the retention of medical records, patient access to information, and patient authorization to release data. Customer agrees that it will obtain any necessary patient consent before using the Services (including, without limitation, the patient portal portion of the Services and associated electronic communications consents) and will apply settings to exclude information from availability in the patient portal portion of the Services as necessary to comply with state or federal law.
e. NO LEGAL ADVICE PROVIDED BY RXNT
Customer and Authorized Users are responsible for understanding and ensuring that RXNT Services are used in accordance with all state and federal laws, standards, and policies imposed by government healthcare programs, state departments, state boards, or other applicable state and federal bodies.
10) NO WARRANTIES; DISCLAIMERS
THE SERVICES ARE PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS, AND RXNT MAKES NO WARRANTIES FOR THE SAME OR OTHERWISE IN CONNECTION WITH THIS AGREEMENT, AND RXNT HEREBY DISCLAIMS ALL WARRANTIES OTHER THAN THOSE EXPRESSLY STATED IN OTHER PROVISIONS OF THIS AGREEMENT, INCLUDING, WITHOUT LIMITATION, ANY WARRANTY THAT THE SERVICES WILL BE UNINTERRUPTED, ERROR-FREE, OR WITHOUT DELAY, AND THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. WHILE RXNT TAKES REASONABLE PHYSICAL, TECHNICAL, AND ADMINISTRATIVE MEASURES TO SECURE THE SERVICES, RXNT DOES NOT GUARANTEE THAT THE SERVICES CANNOT BE COMPROMISED. RXNT DISCLAIMS ANY WARRANTY REGARDING ANY PERCENTAGE OF COLLECTION OF CLAIMS FOR CUSTOMER OR AUTHORIZED USERS.
YOU UNDERSTAND AND AGREE THAT THE OUTPUTS GENERATED BY THE SERVICE ARE INTENDED TO SUPPORT—BUT NOT REPLACE—CLINICAL JUDGMENT, AND SHOULD BE REVIEWED AND VALIDATED BY A QUALIFIED HEALTHCARE PROFESSIONAL BEFORE INCLUSION IN THE MEDICAL RECORD. WE DO NOT WARRANT, GUARANTEE, OR MAKE ANY REPRESENTATION, NOR SHALL WE BE RESPONSIBLE FOR (A) THE CORRECTNESS, ACCURACY, RELIABILITY, COMPLETENESS, OR CURRENCY OF THE SERVICE; OR (B) ANY RESULTS ACHIEVED OR ACTION TAKEN BY YOU IN RELIANCE ON THE SERVICE OR THE OUTPUT OF THE SERVICE. ANY DECISION, ACT, OR OMISSION OF YOURS THAT IS BASED ON THE SERVICE OR OUTPUT OF THE SERVICE IS AT YOUR OWN AND SOLE RISK. THE SERVICE AND THE OUTPUT ARE PROVIDED AS A CONVENIENCE ONLY AND DO NOT REPLACE THE NEED TO REVIEW THE OUTPUT ACCURACY, COMPLETENESS, AND CORRECTNESS.
11) ARTIFICIAL INTELLIGENCE FEATURES
RXNT utilizes artificial intelligence features internally to provide Customer and Authorized Users support and to support business operations (AI). In addition, our Services incorporate features that generate content using artificial intelligence (AI-Feature Content). Customer and Authorized Users acknowledge and agree that:
- AI and AI-Feature Content do not replace the clinical judgment, expertise, or experience of Customer or Authorized Users. AI and AI-Feature Content are not a source of medical advice.
- AI does not replace business judgment, expertise, or experience of Customer or Authorized Users. Customer and Authorized Users will not rely on AI or AI-Feature Content.
- AI and AI-Feature Content cannot guarantee specific outcomes or results. Even with accurate and complete data, the results generated may not always be correct due to inherent limitations or potential for hallucinations. Inaccurate or incomplete data further increases the risk of misleading or unreliable output. RXNT is not responsible for the accuracy of the outputs or use of source attribute information, including that which may be modified by the Customer or Authorized Users.
- Customer and Authorized Users are solely responsible for evaluating the AI and AI-Feature Content and making final decisions regarding patient care. RXNT shall not be liable for any damages, losses, or liabilities arising from the use or misuse of AI or AI-Feature Content.
- Customer and Authorized Users are solely responsible for obtaining all required express consents before utilizing AI, artificial intelligence features, and AI-Feature Content.
By using AI-Feature Content, Customer and Authorized Users acknowledge that they have read and agree to these terms. Customer and Authorized Users further acknowledge that they accept the risks associated with AI-Feature Content and the artificial intelligence features.
RXNT shall not be liable for any direct, indirect, incidental, special, consequential, or exemplary damages, including but not limited to, damage or injury (including death) to Customer, Authorized Users, a patient, other person, or tangible property arising from use of the feature or use or reliance upon the AI or AI-Feature Content.
12) MUTUAL CONFIDENTIALITY
Definition of Confidential Information. Confidential Information means all non-public information disclosed by a party (Discloser) to the other party (Recipient), whether orally or in writing, that is designated as confidential or that reasonably should be understood to be confidential given the nature of the information and the circumstances of disclosure (Confidential Information). RXNT's Confidential Information includes, without limitation, the non-public portions of the Services, software, programming, code, and documentation, and other written materials pertaining thereto, methodologies, processes, inventions, business strategies, client lists, derivatives, and information regarding product development. Confidential Information shall remain at all times the property of Discloser. Confidential Information excludes information that: is or becomes generally known to the public without breach of any obligation owed to Discloser; was known to the Recipient before its disclosure by the Discloser without breach of any obligation owed to the Discloser; is received from a third party without breach of any obligation owed to Discloser; or was independently developed by the Recipient without use or access to the Confidential Information.
Protection of Confidential Information. The Recipient must use the same degree of care that it uses to protect the confidentiality of its own confidential information (but in no event less than reasonable care), not to disclose or use any Confidential Information of the Discloser for any purpose outside the scope of this Agreement. The Recipient must make commercially reasonable efforts to limit access to Confidential Information of Discloser to those of its employees, contractors, and clients (as the case may be) who need such access for purposes consistent with this Agreement and who have signed confidentiality agreements with Recipient no less restrictive than the confidentiality terms of this Agreement. The Recipient may disclose Confidential Information (i) to the extent required by law or legal process; (ii) to its legal or financial advisors, provided that such advisors are bound by a duty of confidentiality that includes use and disclosure restrictions; and (iii) as required under applicable securities regulations. In addition, each Party may disclose the terms and conditions of this Agreement on a confidential basis to current and prospective investors, acquirers, and lenders and their respective legal and financial advisors in connection with due diligence activities.
13) AMA AND ADA CONTENT
AMA Content. The AMA Content is licensed to Customer as follows: RXNT grants Customer a non-exclusive license for the duration of the Services to use such materials for Customer’s internal use solely with the Services, with the right to make additional copies of the material for such duration and purpose (Licensed Documentation). AMA Content means the coding work of nomenclature and codes for reporting of healthcare services from the print publication Current Procedural Terminology, Fourth Edition, and the data file of Current Procedural Terminology (CPT) published by the American Medical Association in the English language as used in the United States. AMA Restrictions: Customer may not use outside the United States, publish, distribute, or create any derivative work (including without limitation translation), transfer, sell, lease, license or otherwise make available the AMA Content, or a portion or copy of such content, except as expressly provided in this Agreement. This sublicense is limited to one user for each active provider associated with Customer’s account. Customer is responsible for seeking additional user licenses directly from the American Medical Association if it requires more than one user license per active provider. CPT is a copyright and a registered trademark of the American Medical Association.
ADA Content. The CDT is licensed to Customer as follows: RXNT grants Customer a non-exclusive, non-transferable right to use the CDT for Customer’s internal use solely with the Services (Licensed Documentation). The CDT means the textual, graphic, and other editorial content included in the ADA developed publications titled CDT 2021: Current Dental Terminology (“CDT”) and all Updates as defined herein. The CDT content includes, but is not limited to, the Code on Dental Procedures and Nomenclature, a glossary, the ADA dental claim form, and other dental information. This License grants End-User the right: (a) to install and use the CDT on End User’s computer system; (b) to retrieve CDT codes, descriptors and nomenclature via commands contained in the Bundled Products for the exclusive use of End User its employees; (c) to reproduce and distribute partial listings of the CDT codes, nomenclature and descriptors in various printed and electronic documents for purposes of claims processing, billing and patient treatment, via commands contained in the Bundled Product; (d) to print limited portions of the CDT solely for the exclusive use of End User; and (e) to print a complete listing of the CDT codes, nomenclature and descriptors solely for the exclusive use of Customer. ADA Restrictions: Customer may not and may not permit anyone else to (a) copy the CDT; (b) alter, amend, change or modify the CDT, including the CDT codes, nomenclature and descriptors or other content of the CDT; (c) remove any copyright or other proprietary notices, labels or marks from the CDT or from output created by using the Services; (d) distribute, sell, assign, lease or otherwise transfer the CDT, including any portion thereof, in any printed, machine-readable or other form to any other person, firm or entity; or (e) use the CDT, whether on a time-sharing, remote job entry or other multiple user arrangement. Customer shall take reasonable measures to maintain the security of the CDT. These restrictions shall not limit Customer’s right to add additional content to the Services, provided that Customer does not alter, amend, change, or modify the CDT and does not claim or otherwise imply that the additional content is owned, created, approved, or endorsed by ADA. Customer acquires no proprietary interest in the CDT, or any portion thereof. Except for the limited rights expressly granted to End User herein, this Agreement, all other rights in the CDT are owned and retained by ADA. EXCEPT AS EXPRESSLY STATED HEREIN, THE CDT IS PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, WARRANTIES OF PERFORMANCE OR MERCHANTABILITY, OR FITNESS FOR A PARTICULAR PURPOSE. CUSTOMER BEARS ALL RISK RELATING TO QUALITY, ACCURACY, AND PERFORMANCE OF THE CDT.
Provisions Relating to Intelligent Medical Objects, Inc. (“IMO”). RXNT’s license agreement with IMO requires that certain provisions (IMO Provisions outlined in Attachment C) be included in this Agreement with respect to the use by Customer and Customer’s end users of Services in which IMO’s intellectual property is embedded. The parties to this Agreement further acknowledge and agree that the IMO Provisions may be modified from time to time by IMO and that any such modifications shall be binding upon the parties hereto.
14) LIMITS ON LIABILITY
Consequential Damages. EXCEPT WITH RESPECT TO GROSS NEGLIGENCE OR INTENTIONALLY HARMFUL ACTS, IN NO EVENT WILL RXNT BE LIABLE TO LICENSEE FOR ANY INCIDENTAL, INDIRECT, SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES, REGARDLESS OF THE NATURE OF THE CLAIM, INCLUDING, WITHOUT LIMITATION, LOST PROFITS, COSTS OF DELAY, ANY FAILURE OF DELIVERY, BUSINESS INTERRUPTION, COSTS OF LOST OR DAMAGED DATA OR DOCUMENTATION OR LIABILITIES TO THIRD PARTIES ARISING FROM ANY SOURCE, EVEN IF RXNT HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. THIS LIMITATION UPON DAMAGES AND CLAIMS IS INTENDED TO APPLY WITHOUT REGARD TO WHETHER OTHER PROVISIONS OF THIS AGREEMENT HAVE BEEN BREACHED OR HAVE PROVEN INEFFECTIVE.
Limit. RXNT’s TOTAL LIABILITY FOR THE CUMULATIVE CLAIMS ARISING FROM OR RELATING TO THIS AGREEMENT, INCLUDING, WITHOUT LIMITATION, ANY CAUSE OF ACTION SOUNDING IN CONTRACT, TORT, OR STRICT LIABILITY, SHALL NOT EXCEED THE TOTAL AMOUNT OF ALL LICENSE FEES PAID TO RXNT BY LICENSEE DURING THE TWELVE (12) MONTH PERIOD BEFORE THE ACT, OMISSION, OR EVENT GIVING RISE TO SUCH LIABILITY. THIS LIMITATION OF LIABILITY IS INTENDED TO APPLY WITHOUT REGARD TO WHETHER OTHER PROVISIONS OF THIS AGREEMENT HAVE BEEN BREACHED OR HAVE PROVEN INEFFECTIVE. Customer acknowledges and understands that the disclaimers and limitations of liability outlined in this Agreement form an essential basis of the contract between the Parties and were a fundamental inducement to RXNT to enter into this Agreement, and that absent such disclaimers, exclusions and limitations of liability, the terms and conditions of this Agreement would be substantially different.
15) TERM, TERMINATION, AND RETURN OF DATA
a. Term
The applicable Services will continue for the duration of one (1) year and will be automatically extended for additional consecutive terms unless either party provides written notice of termination of no less than sixty (60) days prior to extension. This Agreement continues until all the Services are terminated.
b. Termination for Material Breach
Either party may terminate this Agreement and the applicable Subscription Summary if the other party materially breaches any term of the Agreement or the Subscription Summary and does not cure the breach within thirty (30) days of written receipt of notice of breach. Additional terms are in the Term, Termination, and Return of Data Policy FAQ page.
c. Return of Data
RXNT will have no obligation to provide Customer Information to Customer upon termination of this Agreement. It is the sole responsibility of Customer to export Customer Information and data before termination of this Agreement or the associated Subscription Summary. Notwithstanding the foregoing, RXNT may retain Customer Information for 60 days from such termination, and RXNT may provide Customer access to such information upon Customer’s request. For additional information, please see the Return of Data Policy FAQ (Attachment G).
d. Customer Actions upon Termination
Upon termination, Customer must pay any unpaid fees and destroy all RXNT property in Customer’s possession. Customer, upon RXNT’s request, will confirm in writing that it has complied with this requirement.
e. Suspension or Termination of Service for Violation of Law or the Agreement
RXNT may immediately suspend or terminate, with or without notice, the Services and remove applicable Customer Information if it, in good faith, believes that, as part of using the Services, Customer or its Authorized Users may have violated a law or any term of this Agreement.
f. Modifications to Services. RXNT reserves the right to change the availability of any feature, function, or content relating to the Services at any time, without notice or liability to Customer.
16) INDEMNITY
Customer’s Indemnification Obligations. To the extent allowed by applicable law, Customer must indemnify, defend, and hold harmless RXNT against all third-party claims (including without limitation by governmental agencies), demands, damages, costs, penalties, fines, and expenses (including reasonable attorneys’ fees and costs) arising out of or related to:
- Customer or Authorized Users’ use of the Services,
- Customer or Authorized Users’ breach of any term in this Agreement,
- any unauthorized use, access, or distribution of the Services by Customer or Authorized Users,
- Customer or Authorized Users’ breach of any third party’s patent, trademark, copyright, trade secret, or other intellectual property rights, or
- violation of any individual’s privacy rights related to information submitted under Customer or Authorized Users’ account, or fraudulent, invalid, duplicate, incomplete, unauthorized, or misleading information submitted under Customer’s account, by Customer, or by Authorized Users.
RXNT’s Indemnification Obligations. To the extent allowed by applicable law, RXNT must indemnify, defend, and hold harmless Customer against all third-party claims (including without limitation by governmental agencies), demands, damages, costs, penalties, fines, and expenses (including reasonable attorneys’ fees and costs) arising out of or related to allegations that Customer’s use of the Services in accordance with these terms infringes or misappropriates such third party’s patent, trademark, copyright, trade secret or other intellectual property rights. The foregoing obligation does not apply to the extent that such infringement or appropriation arises from: (a) Customer Information or Customer Content; (b) access to or use of the Services in combination with any hardware, system, software, network, or other materials not provided by RXNT or specified for Customer’s use; or (c) modification of the Services other than by or on behalf of RXNT.
Indemnification Procedures. The party seeking indemnification (“Indemnitee” ) shall: (a) promptly notify the indemnifying party (“Indemnitor”) in writing of any such claim, (b) give sole control of the defense and settlement of any such claim to Indemnitor (provided that Indemnitor may not settle any claim in a manner that adversely affects Indemnitee’s rights, imposes any obligation or liability on Indemnitee or admits liability or wrongdoing on the part of Indemnitee without Indemnitee’s prior written consent), and (c) provide all information and assistance reasonably requested by Indemnitor, at Indemnitor’s expense, in defending or settling such claim. Indemnitee may join in defense with counsel of its choice at Indemnitee’s own expense.
17) GOVERNING LAW
a. Governing Law
This Agreement is governed by the laws of the State of Maryland (without regard to conflicts of law principles) for any dispute between the parties or relating in any way to the subject matter of this Agreement.
b. Consent to Jurisdiction
Customer consents to the personal jurisdiction of and service of process in any federal or state court sitting in the State of Maryland.
c. Equitable Relief
Notwithstanding another provision of this Agreement, RXNT may seek and obtain injunctive and equitable relief in any court of competent jurisdiction without restriction or required process in this Agreement.
d. PROHIBITION OF CLASS AND REPRESENTATIVE ACTIONS
EACH PARTY MAY BRING CLAIMS AGAINST THE OTHER ONLY ON AN INDIVIDUAL PARTY BASIS, AND NOT AS A PLAINTIFF OR CLASS MEMBER IN ANY PURPORTED CLASS OR REPRESENTATIVE ACTION OR PROCEEDING. THE ARBITRATOR MAY NOT CONSOLIDATE OR JOIN MORE THAN ONE PARTY'S CLAIMS, AND MAY NOT OTHERWISE PRESIDE OVER ANY FORM OF A CONSOLIDATED, CLASS, OR REPRESENTATIVE PROCEEDING.
18) OTHER TERMS
a. No Solicit or Hire Clause
Customer acknowledges that RXNT invests considerable time and expense in the training of its employees and independent subcontractors in the services to be provided under this Agreement. Customer agrees that for the full term of this Agreement, and 1 year after its termination, Customer will not solicit or employ in any capacity, whether as a direct employee or independent contractor providing similar services to Customer as RXNT, any person employed by RXNT at any time during the term of this Agreement whose duties involve providing the Services, whether for Customer or other RXNT customers.
b. Consent to Electronic Notice, Communications, and Transactions
By using the Services, Customer agrees to conduct business electronically and acknowledges that Customer has read the Customer Disclosures: Electronic Business Transactions, Signing Documents Electronically, and Receiving Electronic Notices and Disclosures, located at https://www.rxnt.com/customer-disclosures/.
For purposes of messages and notices about the Services (including, without limitation, collections and payments issues), RXNT may send email notices to the email address associated with Customer's account or provide in-service notifications. For certain notices (e.g., notices regarding termination or material breaches), RXNT may send notices to the postal address provided by Customer. RXNT has no liability associated with Customer's failure to maintain accurate contact information within the Services or its failure to review any emails or in-service notices. Customer will have the ability to enter into agreements, authorizations, consents, and applications; make referrals; order lab tests; prescribe medications; or engage in other transactions electronically. CUSTOMER AGREES THAT ITS ELECTRONIC SUBMISSIONS VIA THE SERVICES IN CONNECTION WITH SUCH ACTIVITIES CONSTITUTE ITS AGREEMENT TO BE BOUND BY SUCH AGREEMENTS AND TRANSACTIONS AND APPLIES TO ALL RECORDS RELATING TO SUCH TRANSACTIONS. Customer represents and warrants that it has the authority to take such actions.
c. Entire Agreement and Changes
This Agreement and the Subscription Summary constitute the entire agreement between the parties and supersede all prior or contemporaneous negotiations or agreements, whether oral or written, related to this subject matter. Customer is not relying on any representation concerning this subject matter, oral or written, not included in this Agreement. No representation, promise, or inducement not included in this Agreement is binding. No modification or waiver of any term of this Agreement is effective unless signed by both parties. Notwithstanding the foregoing, RXNT may modify this Agreement by posting modified Terms of Service on the RXNT website. Changes will always prevail from the date of publication at the website www.RXNT.com/customer-agreement. RXNT will make commercially reasonable efforts to provide thirty (30) days’ notice of changes to this Agreement. To receive notices, Customer must subscribe using the “Subscribe to Updates” button on that website. Customer agrees that by continuing to use the Services after posting of the modified Terms of Service, Customer agrees to be bound by the changes.
d. Feedback
If Customer or Authorized Users provide feedback or suggestions about the Services, then RXNT (and those it allows to use its technology) may use such information without obligation, compensation, or notification to Customer or Authorized Users.
e. Beta Features
If Customer or Authorized Users are invited to access any beta features of the Services or a Customer or Authorized Users accesses any beta features of the Services, Customer and Authorized Users acknowledge that: (a) such features have not been made commercially available by RXNT; (b) such features may not operate properly, be in final form or fully functional; (c) such features may contain errors, design flaws or other problems; (d) it may not be possible to make such features fully functional; (e) use of such features may result in unexpected results, corruption or loss of data, or other unpredictable damage or loss; (f) such features may change and may not become generally available; and (g) RXNT is not obligated in any way to continue to provide or maintain such features for any purpose in providing the ongoing Services. These beta features are provided AS IS, with all faults. Customer and Authorized Users assume all risk arising from use of such features, including, without limitation, the risk of damage to Customer’s or Authorized Users’ computer system or the corruption or loss of data.
f. No Assignment
Neither party may assign or transfer this Agreement or the Subscription Summary to a third party, except that this Agreement may be assigned (without the consent) as part of a merger, or sale of all or substantially all of the business or assets of a party.
g. Electronic Notice
For purposes of messages and notices about the Services (including, without limitation, collections and payments issues), RXNT may send email notices to the email addresses associated with Customer's account or provide in-service notifications. For certain notices (e.g., notices regarding termination or material breaches), RXNT may send notices to the postal address provided by Customer. RXNT has no liability associated with Customer's failure to maintain accurate contact information within the Services or its failure to review any emails or in-service notices.
h. Independent Contractors and Enforceability
The parties are independent contractors with respect to each other. If any term of this Agreement is invalid or unenforceable, the other terms remain in effect.
i. No Additional Terms
RXNT rejects additional or conflicting terms of a form-purchasing document. If there is an inconsistency between this Agreement and the Subscription Summary, the Subscription Summary prevails.
j. Survival of Terms
All terms survive termination of this Agreement that by their nature survive for a party to assert its rights and receive the protections of this Agreement. The Convention on Contracts for the International Sale of Goods does not apply.
k. Customer Name
RXNT may use Customer's and Authorized User’s name and logo in customer lists and related promotional materials describing Customer as a customer of RXNT, which use must be in accordance with Customer’s trademark guidelines and policies, if any, provided to RXNT.
ATTACHMENT A – Support Policy
Hours of Operation
Practice Management Support: Monday-Friday, 8 am-8 pm (Eastern Time), excluding national holidays.
Clinical Support: Monday-Friday, 8 am-10 pm (Eastern Time), excluding national holidays.
Scheduled Maintenance
Scheduled maintenance may occur between 11 pm-7 am (Eastern Time), during weekends and holidays, or with 24-hour notice.
Access to Software Support for RXNT PM, RXNT EHR, and RXNT ERX
Click the Help tab on the RXNT product dashboard (or any page in RXNT PM, RXNT EHR, and RXNT ERX) to access self-help and feature guides, knowledgebase articles, video tutorials, FAQs, and more.
If you cannot find your answer under the Help tab, choose from one of the following options to contact RXNT customer support:
- Email your Practice Management Support questions to [email protected] or call 410-709-4827.
- Email your Clinical Support questions to [email protected], and your Identity & Token Support questions to [email protected] or call 410-907-7976.
- Chat with us online using the Chat tab on the RXNT product dashboard (or any page in RXNT PM, RXNT EHR, and RXNT ERX)
ATTACHMENT B – Pricing Policy
Pricing & Billing Policies for your RXNT Account
General Terms
Billing Frequency and Methods
Billing |
Frequency and Method |
Subscription fees and transactional fees |
Billed monthly or annually. |
Data storage fees |
NO CHARGE except for a historic database extension requested by Customer, whereby the fees will be outlined in a quote. |
Data import fees |
NO CHARGE for an initial import of patient demographics and insurance information when provided in the required format. Fees for incorrectly formatted imports or additional imports will be outlined in a quote. |
Onboarding |
NO CHARGE for onboarding during the standard onboarding period. The standard onboarding period begins at the time of enrollment and terminates 30-60 days following enrollment, depending on the Service Customer subscribed to (“Standard Onboarding Period”). If Customer foregoes onboarding during the Standard Onboarding Period or needs more time than allotted during the Standard Onboarding Period, Customer may purchase additional onboarding (“Additional Onboarding Period”). ERX Only:
EHR Bundle:
Practice Management and Full Suite Bundle:
An Additional Onboarding Period will be invoiced in advance of the onboarding provided. |
Training |
NO CHARGE for online training during the Standard Onboarding Period or an Additional Onboarding Period. Customer may purchase additional online training (“Additional Training”) for a fee of $200 per hour. Additional Training will be invoiced in advance of the training provided. |
Support |
NO CHARGE. |
Data Export |
NO CHARGE for data export utilizing the data export feature within the Services during the term of the Agreement. Custom data exports may be subject to additional fees. |
- Upgrading or Downgrading Subscriptions. New licenses purchased will be charged on a pro rata monthly basis. Customer may remove licenses by providing RXNT a written notice 60 days before the applicable Agreement renewal date. Applicable payer pass-through fees, if any, shall be charged in addition to the foregoing fees.
- Fees: All fees charged by RXNT are described in RXNT’s Pricing Policy page and are determined by the subscription level selected and specific provider characteristics (for example, Physician or Non-Physician Provider, or full-time or part-time). All prices may change with 30 days’ electronic notice. You are responsible for keeping your email address updated with RXNT. Mailing fees (example, for mailings like paper insurance claims or paper patient statements) may be increased at any time to reflect a change in the USPS postage, processing costs, or business needs.
Billing & Other Terms
- Account Changes: RXNT bills immediately upon the initiation of onboarding and each month or year thereafter. Monthly billing is merely a financing option and does not affect the term of this Agreement. Except for account cancelations or terminations, which are covered under the RXNT Terms of Service, changes must be made sixty (60) days before renewal.
- No Refunds/Credits: All fees are nonrefundable and non-cancellable. RXNT does not refund or credit subscription fees for partial months, any portion of a prepaid plan upon a deactivation of an Authorized User or account cancellation, or for Additional Onboarding Periods, or Additional Training requested by the Customer, that is unused or unattended. Customer is responsible for all fees (including any monthly minimum) for the entire term of the applicable order or subscription agreement.
- Onboarding Start Date: Customers can secure a future Onboarding Start Date by placing a non-refundable deposit. By submitting a deposit, Customer is responsible for all fees for the entire term of the applicable order or subscription agreement. All fees are nonrefundable and non-cancellable. This Agreement will automatically renew upon the anniversary of the Onboarding Start Date.
- Practices: Must have at least one active Provider within a Practice for the Practice to remain active.
- Multi-Location Provider: Providers within an account can be linked to more than one location.
Customer Support Plans & Fees
Phone, Email, and Live Chat Support
- All subscription levels include access to customer support by email, live chat, and phone.
Assisted Payer Enrollment Service
- Assisted enrollment services include clearinghouse sign-up and setup of electronic services with insurance companies.
- Unlimited number of payers on your initial enrollment. Subsequent payers are also included.
- Assisted enrollments are included for all customers without additional fees during the Standard Onboarding Period.
Electronic Clearinghouse Services & Fees
Electronic Claims Submission (ANSI 837)
- Electronic claims submission service includes sending electronic claims in the ANSI 837 format to RXNT's Clearinghouse.
- No charge for Per Provider Per Month subscription levels.
Electronic Remittance Advice (ANSI 835)
- Electronic remittance advice service includes receiving electronic remittance advice messages from RXNT’s Clearinghouse in the ANSI 835 format.
- No charge for Per Provider Per Month subscription levels.
Electronic Real-Time Insurance Eligibility Services (ANSI 270/271)
- Electronic real-time insurance eligibility services include performing electronic verification of insurance benefits from RXNT’s Clearinghouse in the ANSI 270/271 format.
- No charge for Per Provider Per Month subscription levels.
- Termination of Remittance Services: If Customer desires to discontinue electronic remittance services, then Customer must contact the insurance companies directly to request termination.
Electronic Prescribing of Controlled Substances (EPCS) using RXNT EHR or RXNT ERX
Customers wanting a provider to be able to prescribe controlled substances electronically need access to RXNT EPCS service. The cost is $85.00 per provider, per company account, per year. We provide the provider identity proofing and credentialing required per the IAL2 standard or higher.
Provider Communications Service
Customers wanting to send appointment visit reminders or patient statements via text, email, or phone need access to RXNT’s Provider Communications service. The cost to enable RXNT’s Provider Communications Service, which includes eFax, e-mail, text messages, and phone calls, is $6.25 per month. Each Provider Communication by text is $.02 per text. Each Provider Communication by call is $.04 per call (reminders only). Each Provider Communication by eFax (both sent and received) is $.02 per minute.
The cost to enable RXNT’s Provider Communications Service will increase from $6.25 per month to $15.00 per month if the Customer’s practice sends over 6,000 text message reminders and/or patient statements in a single day. Once Customer exceeds this threshold, Customer may not revert to the $6.25 per month Provider Communications Service tier. Transactional rates still apply.
Direct Email
Customers wanting a provider to be able to securely send and receive patient information to other providers (outside of RXNT) need access to RXNT Direct Email. The cost is $14.00 per month for the practice and $17.00 per month for each email address needed.
Immunization Interface
Customers wanting to electronically send patient immunization records to state immunization registries need access to the RXNT Immunization Interface. There is a one-time set-up cost of $350.00 payable upfront. The monthly costs vary depending on the service needed:
- Uni-directional Immunization Reporting - $30.00 provider per month
- Bi-directional Immunization Reporting - $42.00 provider per month
Custom Smart Form
Customers purchasing RXNT EHR (electronic health records) may request a Custom Smart Form subject to the following terms and conditions:
- Customer may request five (5) Custom Smart Forms at no cost as follows: The Custom Smart Form order has to be made in one (1) initial order within sixty (60) days following the Customer’s enrollment (the “Initial Order”).
- Customer may purchase additional Custom Smart Forms as part of the Initial Order at a rate of $100/additional form.
- Customer must provide all Custom Smart Forms they are requesting in the Initial Order to their RXNT Onboarding Coach before their consultation.
- A Custom Smart Form order will be delivered within 4-6 weeks from the Customer’s consultation, pending successful payment. RXNT will not commence work on a Custom Smart Form order until payment is received. A delayed payment will adversely affect the delivery timelines outlined.
- Fees related to a Custom Smart Form order will be charged to the payment source on file (for Customer) immediately following the consultation or revision request.
- A Custom Smart Forms order i) not provided in advance of the Customer’s consultation or ii) received more than sixty (60) days following the Customer’s enrollment is considered a subsequent order (“Subsequent Order”). A Subsequent Order may be placed at a rate of $500/order and $125/form. For example, a second order containing one (1) form would cost $625. Similarly, a second order containing three (3) forms would cost $875.
- Revisions to a Custom Smart Form order (“Revision Request”) by Customer may be requested within fourteen (14) days following RXNT’s delivery of the Custom Smart Form order (“Delivery”) for a fee of $50/revised form. A Revision Request received more than fourteen (14) days following Delivery will be available for $125/revised form.
- A Revision Request will be delivered within 4-6 Weeks from the delivery, pending successful payment.
- A cancellation fee of $200 will be charged to the payment source on file (for Customer) in each of the following situations:
- The Customer fails to provide documentation one (1) business day in advance of the scheduled consultation for the second time;
- The Customer cancels a consultation with less than 24 hours’ notice; or
- The Customer does not show up for a scheduled consultation.
Paper Claims Mailing Services
If Customer desires, RXNT can print and mail claims on your behalf. The cost is $0.40 per claim. Postage and mailing materials are all included. NOTE: Customer does NOT have to use this service. Customer may print their claims using their own printer and mail those claims, and there is no fee charged by RXNT.
Patient Payment Credit Card Services
If Customer would like to utilize RXNT’s payment processing service, Customer must i) turn it on for all providers within its practice and ii) set up a merchant account with our merchant services partner, Nuvei. The rate Customer will pay for processing credit card payments will be quoted by Nuvei.
To utilize RXNT’s payment processing service, the cost is $15.00 per provider, per month. This includes the ability for the Customer to take patient payment through the RXNT Scheduler and/or Billing software, and for the Customer to make payment through the RXNT Patient Bill Pay Portal or through the RXNT Patient Portal.
Patient Statement Mailing Service Fees
- Sending batches of patient statements to Change Health Care Clearinghouse for printing and mailing (postage is included).
- Statement Service: $0.90/statement. Mailing fees may be increased at any time to reflect a change in the USPS postage or processing costs.
- Change of Address Service (NCOA): $0.30/address change returned.
- No fee for printing of patient statements to your own printer from RXNT.
Data Storage
There is no charge for data storage except for a historic database extension requested by Customer whereby the fees will be outlined in a quote. For a list of what information Customer may import and store in RXNT, please refer to the following link: https://help.rxnt.com/hc/en-us/articles/360035878934-Import-Data-into-RXNT#what-can-rxnt-import-from-my-previous-system--0-0.
ATTACHMENT C – Third Party Terms
PROVISIONS RELATING TO INTELLIGENT MEDICAL OBJECTS, INC. (“IMO”)
IMO END-USER License RIDER Language (“EULA”)
The RXNT Services contain Problem IT terminology from Intelligent Medical Objects, Inc. (“IMO”) (the “Service”). The Service and the RXNT Services are separate products provided by separate entities. Your use or your End Users use of the Service (collectively the “END-USER”) in conjunction with the Software is subject to the terms and conditions of this End User License Agreement (“EULA”).
In consideration of the rights and restrictions contained herein, END-USER agrees as follows:
- Grant of License
The license granted herein is a non-exclusive, non-transferable license to use the Service solely in conjunction with the Software for internal use: (i) in a clinical setting; and (ii) in a non-production/non-clinical setting for backup, archival, support, testing, training and demonstration purposes; provided END-USER complies with the restrictions set forth in Section 2.
- Restrictions
END-USER shall not cause or permit others to copy, duplicate, redistribute, loan, rent, retransmit, publish, license or sublicense or otherwise transfer, or commercially exploit, the Service, in whole or part. END-USER shall not prepare derivative works or incorporate the Service, in whole or part, in any other system or work; or reverse engineer, decompile, disassemble, decrypt, translate, alter, adapt or modify the Service, in whole or part.
- Ownership
This EULA provides only a license of rights to use the Service and does not provide for the sale or other transfer of title. Except for third party content included in the Service, IMO has and shall have exclusive title to and ownership of all of its products, including the Service and of all of its sub-parts and components, and of all updates, modifications, alterations, customizations, derivative works, revisions or enhancements thereof, and of all software, source code, and trade secrets, and proprietary research, equations, screens, techniques, methodology, analysis, programming or know-how thereof.
Any ideas or requests for terms submitted by END-USER to the Software vendor or IMO for inclusion in the Service shall be considered part of a derivative work of the Service and shall be owned by IMO with all rights assigned by END-USER to IMO. END-USER shall not be charged for such regular inclusion of added terms. END-USER will have a perpetual, non-exclusive license to use, display or modify these requested terms apart from the Service.
- Technical Warranty
The Service, as provided by IMO, does not include any disabling devices such as devices that result in the electronic recapture of programming, undocumented functions, passwords, keys, security devices or trap doors, or any computer viruses.
- Disclaimer of Warranties
EXCEPT FOR WARRANTIES THAT MAY NOT BE DISCLAIMED AS A MATTER OF LAW OR THAT ARE INCLUDED HEREIN, THE SERVICE IS PROVIDED ON AN "AS IS" BASIS AND IMO MAKES NO REPRESENTATIONS OR WARRANTIES WHATSOEVER, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO REPRESENTATIONS OR WARRANTIES REGARDING THE ACCURACY OR NATURE OF THE SERVICE, NONINFRINGEMENT, COMPATIBILITY, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE.
Any warranties expressly provided herein do not apply if: (i) the END-USER alters, mishandles or improperly uses, stores or installs all, or any part, of the Service; (ii) the END-USER uses, stores or installs the Service on a computer system which fails to meet the specifications for the Software; or (iii) the breach of warranty arises out of or in connection with acts or omissions of persons or entities other than IMO.
- Assumption of Risk
THE END-USER ACKNOWLEDGES THAT THE SERVICE IS NOT A SUBSTITUTE FOR THE CARE PROVIDED BY LICENSED HEALTH CARE PRACTITIONERS. AS BETWEEN THE END-USER AND IMO, THE END-USER HEREBY ASSUMES FULL RESPONSIBILITY FOR: (A) ITS USE OF THE SERVICE; AND (B) ENSURING THE APPROPRIATENESS OF USING AND RELYING UPON THE INFORMATION IN VIEW OF ALL ATTENDANT CIRCUMSTANCES, INDICATIONS, AND CONTRAINDICATIONS. IMO SHALL NOT BE RESPONSIBLE AND HAS NO LIABILITY TO ANY PERSON FOR: (A) ANY ERRORS, MISSTATEMENTS, INACCURACIES OR OMISSIONS REGARDING CONTENT DELIVERED THROUGH THE SERVICE; (B) ANY DELAYS IN OR INTERRUPTIONS OF SUCH DELIVERY; OR (C) ANY DATA OR INFORMATION INPUT INTO THE SERVICE BY THE END-USER. ADDITIONALLY, IMO UNDERTAKES NO OBLIGATION TO SUPPLEMENT OR UPDATE CONTENT OF THE SERVICE.
THE SERVICE DOES NOT ENDORSE DRUGS, DIAGNOSE PATIENTS, OR RECOMMEND THERAPY. THE SERVICE IS AN INFORMATIONAL RESOURCE DESIGNED TO ASSIST LICENSED HEALTH CARE PRACTITIONERS IN DOCUMENTING THE CARE OF THEIR PATIENTS. THE INFORMATION CONTAINED WITHIN THE SERVICE IS INTENDED FOR USE ONLY BY PHYSICIANS AND OTHER HEALTHCARE PROFESSIONALS WHO SHOULD RELY ON THEIR CLINICAL DISCRETION AND JUDGMENT IN DIAGNOSIS AND TREATMENT.
- Disclaimer of Liability
EXCEPT FOR IMO’S OBLIGATIONS UNDER SECTION 8(B), IN NO EVENT SHALL IMO BE LIABLE TO ANY PERSON INCLUDING, BUT NOT LIMITED TO END-USER AND PERSONS TREATED BY OR ON BEHALF OF END-USER FOR ANY CONSEQUENTIAL, INDIRECT, SPECIAL, INCIDENTAL, OR PUNITIVE DAMAGES ARISING OUT OF OR RELATED TO THIS EULA OR THE SERVICE. IMO’S TOTAL LIABILITIES ARISING OUT OF OR RELATED TO THIS EULA ARE LIMITED TO THE FEES RECEIVED BY IMO FROM THE SOFTWARE’S LICENSOR FOR END-USER’S USE OF THE SERVICE.
- Indemnification
- By END-USER. END-USER agrees to indemnify, defend, and hold IMO harmless from any claims, costs, liabilities, judgments, attorneys’ fees, settlements, penalties or other losses in all causes including, but not limited to losses for tort, personal injury, medical malpractice or product liability arising out of or relating to: (a) the END-USER’s use of the Service; (b) any data or information input into the Service by END-USER; (c) END-USER’s negligence or intentional misconduct; and (d) any breach of this EULA by END-USER. In the event that END-USER indemnifies IMO, then: (i) END-USER will retain qualified counsel with demonstrable experience defending claims of the type to be defended, who shall be preapproved by IMO; and (ii) END-USER agrees to let IMO participate in the defense of any action, at IMO’s option and expense.
- By IMO. IMO agrees to indemnify, defend, and hold END-USER harmless against third party claims, costs, liabilities, judgments, attorneys’ fees, settlements, and penalties brought against END-USER arising out of, related to, or alleging that the IMO Service infringes on a United States patent, trademark or copyright of a third party (collectively “Indemnified Claim”); provided END-USER promptly, but within thirty (30) days, notifies IMO in writing of such Indemnified Claim. IMO shall have sole control of the defense of any Indemnified Claim, including appeals, negotiations, and any settlement or compromise thereof; provided END-USER will have the right to approve the terms of any settlement or compromise that restricts its rights granted under this Agreement or subjects it to any ongoing obligations. IMO shall have no indemnification obligation to END-USER to the extent that an Indemnified Claim arises out of: (i) END-USER’S violation of this EULA; (ii) information incorporated into the Service by END-USER or Software vendor; (iii) a modification or addition to the Service made by END-USER or Software vendor; or (iv) the use of the Service in combination with any program or equipment or any part thereof not furnished or approved by IMO.
- Intellectual Property Disclaimers; Use of Trademarks
END-USER will not alter, cover or remove any trademark, copyright or other proprietary rights notice placed by IMO or a third party in or on the Service. END-USER will not use or modify any IMO or third party trademarks, trade names, service marks, corporate names or logos or those of its affiliates (collectively “Marks”) or any advertising materials containing any of the foregoing unless it has obtained the prior written approval of IMO, which may be withheld for any reason. Goodwill associated with the Marks inures solely to IMO and the respective third-party owners. END-USER acknowledges and agrees that it shall not, directly or indirectly, do anything inconsistent with the validity, ownership, distinctiveness or integrity of the Marks, or the goodwill attaching thereto, nor shall it assist any third party in doing so.
- END-USER Documentation
END-USER is responsible for generating any user documentation related to the Service.
- Security
END-USER shall establish the appropriate firewalls and security systems, such that the Service is accessed only by authorized employees or contractors of END-USER and is not used in a manner that would violate the terms of this EULA.
- Third Party Beneficiary
END-USER agrees that IMO shall be, and is hereby, named as an express third-party beneficiary of this EULA for the purpose of enforcing at law and at equity all rights under this EULA against END-USER, the covenants of END-USER and the warranty disclaimers and limitations of liability set forth in this EULA, whether or not such provisions make specific reference to IMO or the Service.
- Term and Termination
The term of this EULA begins upon installation of the Software and/or Service and continues for the term specified in END-USER’s Software license agreement. This EULA may be terminated by IMO or Software vendor at any time if: (i) END-USER violates any provision of this EULA; or (ii) Software vendor’s relationship with IMO terminates. If this EULA is terminated for any reason, END-USER agrees to immediately return or destroy all copies of the Service and all companying items and certify the return or destruction thereof.
- Third Party Content
END-USER acknowledges that the Service includes third-party content. END-USER agrees to the terms and conditions outlined in Schedule A of this EULA.
- General
END-USER will hold the terms of this EULA confidential. END-USER will ensure that anyone with authorized access to the Service will comply with the provisions of this EULA and Schedule A. If any provision of this EULA is determined to be unenforceable, the rest of this EULA will remain in full force. Headings in this EULA are for convenience only and are not part of this EULA. The delay or failure to assert a right herein or to insist upon compliance with any term or condition of this EULA shall not constitute a waiver of that right or excuse a subsequent failure to perform any term or condition. END-USER may not assign any of the rights herein without prior written approval from IMO. This EULA will be governed by the State of Illinois without regard to choice-of-law principles. The courts of the State of Illinois and/or the United States District Court for the Northern District of Illinois shall have exclusive jurisdiction over any action arising under or related to the subject matter of this EULA and the parties agree to submit to the jurisdiction of the courts of the State of Illinois and the United States District Court for the Northern District of Illinois. This EULA is the entire agreement between END-USER and IMO as to the subject matter. Any amendment must be in writing, signed by both END-USER and IMO.
SCHEDULE A-Third Party Content Terms SNOMED CT® Codes
The Service makes use of SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organization (IHTSDO). All rights reserved. SNOMED CT®, was originally created by The College of American Pathologists. “SNOMED” and “SNOMED CT” are registered trademarks of the IHTSDO.
EXHIBIT C-THIRD PARTY CONTENT TERMS AND CONDITIONS SNOMED CT® CODES
The Service includes SNOMED Clinical Terms (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organization (IHTSDO). All rights reserved. SNOMED CT®, was originally created by The College of American Pathologists. “SNOMED” and “SNOMED CT” are registered trademarks of the IHTSDO.
ATTACHMENT D – Business Associate Agreement
This Business Associate Agreement (“BA Agreement”) shall be incorporated into the software and services Terms of Service (“Agreement”) for Customers that are Covered Entities (as defined in the HIPAA Rules) (“Covered Entity”) that provide Protected Health Information (“PHI”) (as defined in the HIPAA Rules) to Networking Technology, Inc. dba RXNT (“RXNT” or “Business Associate”).
- DEFINITIONS AND INTERPRETATION
- Definitions Generally. Capitalized terms used but not otherwise defined in this Agreement (which includes, without limitation this BA Agreement) shall have the meanings ascribed to them by the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”), as amended by the regulations promulgated under the Health Information Technology for Economic and Clinical Health (“HITECH”) Act (Division A, Title XIII and Division B, Title IV of Public L. 111–5) (“HIPAA Rules”). If a term is not defined by HIPAA, it shall have the meaning given in this Agreement, to which this BA Agreement is an Attachment.
- Inconsistencies. If the provisions of this Agreement are inconsistent with HIPAA Rules or its implementing regulations or any binding interpretation thereof (“Regulations”), said conflict will be resolved in favor of the Regulations. To the extent that any such conflicts are nonetheless permitted under the Regulations, the provisions of this Agreement and this BA Agreement will prevail.
- Third Parties. Except as expressly provided for in the Regulations and/or within the terms contained herein, this Agreement and this BA Agreement do not create any rights in third parties.
- PERMITTED USES AND DISCLOSURES BY THE BUSINESS ASSOCIATE
- Permitted Uses. RXNT may use and disclose PHI received from, created for, or received on behalf of the Covered Entity as necessary to perform its obligations under this Agreement and this BA Agreement, to carry out its legal responsibilities, or as otherwise permitted or required by applicable law, including the HIPAA Rules. Such uses and disclosures may include, without limitation, those necessary to facilitate administrative, clinical, or financial healthcare operations, support treatment activities, or maintain business management and operational programs. Business Associate shall limit such uses and disclosures to the minimum necessary to accomplish the intended purpose, in accordance with 45 C.F.R. § 164.502(b).
- Data Aggregation. Except as otherwise limited in this BA Agreement, the Business Associate may use PHI to provide data aggregation services to the Covered Entity to the fullest extent permitted by 45 C.F.R. § 164.504(e)(2)(i)(B) and this Agreement.
- De-Identification. The Business Associate may de-identify PHI in accordance with 45 C.F.R. § 164.514 and use such de-identified data for any lawful purpose. RXNT shall be the exclusive owner of all de-identified data.
- Permitted Disclosures. Business Associate may disclose PHI for its proper management and administration or to carry out its legal responsibilities, provided that: (a) such disclosure is Required by Law; or (b) Business Associate obtains reasonable assurances from the recipient that the PHI will remain confidential, will only be used or further disclosed as Required by Law or for the purpose for which it was disclosed, and that the recipient will notify the Business Associate of any known or suspected breaches of confidentiality.
- Report Violations of Law. The Business Associate may use PHI to report violations of law to appropriate Federal and State authorities, consistent with 45 C.F.R. § 164.502(j)(1).
III. PRIVACY RULE OBLIGATIONS OF THE BUSINESS ASSOCIATE
- Limitations on Disclosures. The Business Associate agrees not to use or disclose PHI other than as permitted or required by this Agreement or as Required by Law. The Business Associate shall not use or disclose PHI in a manner that would violate the Privacy Rule if done by Covered Entity, unless expressly permitted to do so under the Privacy Rule, this Agreement, and this BA Agreement.
- Safeguards against Unauthorized Use. RXNT agrees to use appropriate safeguards to prevent use or disclosure of PHI other than as provided for by this Agreement and this BA Agreement, including implementing administrative, physical, and technical safeguards that reasonably and appropriately protect the Confidentiality, Integrity, and Availability of PHI in electronic media (“ePHI”) that it creates, receives, maintains, or transmits on behalf of the Covered Entity in compliance with the HIPAA Security Rule.
- Mitigation. RXNT shall mitigate, to the extent commercially practicable, any harmful effects that are known to RXNT of a use or disclosure of PHI by RXNT in violation of the requirements of this Agreement or this BA Agreement.
- Agreements with Subcontractors. Covered Entity acknowledges that RXNT may use Subcontractors. RXNT agrees to ensure that any Subcontractor to whom it provides PHI received from, or created or received by RXNT on behalf of Covered Entity, agrees in writing to substantially the same restrictions and conditions that apply through this BA Agreement to RXNT with respect to the PHI.
- Obligations on Behalf of Covered Entity. To the extent the Business Associate carries out an obligation of Covered Entity under the Privacy Rule, the Business Associate must comply with the requirements of the Privacy Rule that apply to Covered Entity in the performance of such obligation, provided Covered Entity advises RXNT of such obligations.
- Access to PHI. The Business Associate shall provide access, at the request of Covered Entity, and in the time and manner reasonably designated by Covered Entity, to PHI in a Designated Record Set, to the Covered Entity to meet the requirements under the Privacy Rule at 45 C.F.R. § 164.524, by making the Services available to Covered Entity under this Agreement. Covered Entity agrees to the fees outlined in Section III (j) for performance of such obligations.
- Amendment of PHI. The Business Associate shall make PHI contained in a Designated Record Set available to Covered Entity for purposes of amendment per 45 C.F.R. § 164.526. The Business Associate shall make any amendment(s) to an Individual’s PHI that the Covered Entity directs or agrees to pursuant to the Privacy Rule, at the request of Covered Entity, by making the Services available to Covered Entity under this Agreement. If an Individual requests an amendment of PHI directly from the Business Associate or its Subcontractors, the Business Associate shall notify Covered Entity in writing promptly after receiving such request. Any denial of amendment of PHI maintained by the Business Associate or its Subcontractors shall be the responsibility of Covered Entity.
- Accounting of Disclosures. The Business Associate shall document disclosures of PHI and information related to such disclosures as would be required for Covered Entity to respond to a request by an Individual for an accounting of disclosures of PHI in accordance with 45 C.F.R. § 164.528, and to reasonably cooperate with Covered Entity in responding to such requests.
- Availability of Information. For the purpose of the Secretary determining Covered Entity’s compliance with the Privacy Rule, the Business Associate agrees to make internal practices, books, and records relating to the use and disclosure of PHI received from, or created or received by the Business Associate on behalf of Covered Entity available to the Covered Entity, or to the Secretary, in a time and manner designated by Covered Entity or the Secretary and not materially disruptive of RXNT’s operations or business, for the purposes of the Secretary determining Covered Entity’s or RXNT’s compliance with the Privacy Rule. All information provided by RXNT under this provision shall remain Confidential Information under this BA Agreement and subject to the restrictions on disclosure of such information as set forth therein.
- Performance of RXNT Obligations. If, in the performance of its obligations outlined in Sections III(e) through (i), and Sections V(a) through (c), RXNT expends time and materials that are materially in addition to the Services to be provided by RXNT under this Agreement, RXNT shall provide Covered Entity with an estimate of the fees for such time and materials. Upon the mutual agreement by Covered Entity and RXNT as to the fees to be charged by RXNT for such time and materials, RXNT shall invoice Covered Entity on a time and materials basis at the agreed-upon rate(s), and Covered Entity shall pay RXNT all such fees under the payment terms of this Agreement.
- Retention of Protected Health Information. Covered Entity understands and agrees that information generated through the use of the Services provided under this Agreement will be retained as necessary by RXNT for purposes of financial reporting, insurance claims, and other legal and business purposes.
l.. Minimum Necessary. When Business Associate uses or discloses PHI, it will use or disclose the PHI to the minimum amount of PHI reasonably necessary to accomplish the purpose of such use or disclosure.
- SECURITY RULE OBLIGATIONS OF THE BUSINESS ASSOCIATE
- Compliance with the Security Rule. The Business Associate agrees to comply with the Security Rule with respect to ePHI and have in place reasonable and appropriate administrative, physical, and technical safeguards to protect the Confidentiality, Integrity, and Availability of ePHI and to prevent the use or disclosure of ePHI other than as provided for by this Agreement and this BA Agreement or as Required by Law.
- Security Incident/Breach Notification Reporting. RXNT shall report to Covered Entity any use or disclosure of PHI not provided for by this Agreement or this BA Agreement of which it becomes aware. RXNT also agrees to notify Covered Entity of any Breach of Unsecured PHI in accordance with 45 C.F.R. § 164.410; such notification shall be made without unreasonable delay and in no event later than 60 calendar days after discovery, as defined in 45 C.F.R. § 164.410(a)(2) and shall comply with the requirements of the HIPAA Breach Notification Rule. RXNT shall also, without unreasonable delay, but in no event later than 60 calendar days after becoming aware of any Security Incident that is not an Unsuccessful Security Incident (defined herein), report the successful Security Incident to Covered Entity. An “Unsuccessful Security Incident” means an immaterial Security Incident that does not result in unauthorized use or disclosure of PHI. Covered Entity acknowledges that such events may occur from time to time, and this paragraph constitutes RXNT’s entire notice of these incidents.
- OBLIGATIONS OF THE COVERED ENTITY
- Notification Regarding Limitations and Restrictions on Disclosure. Covered Entity shall notify the Business Associate of any limitation(s) in its Notice of Privacy Practices of Covered Entity that may affect the Business Associate’s use or disclosure of PHI in accordance with 45 C.F.R. § 164.520.
- Notification of Changes to Limitations and Restrictions on Disclosure. Covered Entity shall notify the Business Associate of any changes in, or revocation of, permission by the Individual to use or disclose PHI, to the extent that such changes may affect the Business Associate’s use or disclosure of PHI.
- Limitations and Restrictions on Disclosure Arising Under Third-Party Agreements. Covered Entity shall further notify the Business Associate in writing of any restriction to the use or disclosure of PHI that Covered Entity has agreed to, which may affect the Business Associate’s use or disclosure of PHI in accordance with 45 C.F.R. § 164.522.
- Requests by Covered Entity. Covered Entity shall not request the Business Associate to use or disclose PHI in any manner that would not be permissible under the Privacy Rule if done by the Covered Entity.
- Device Security. Covered Entity acknowledges and agrees that it is solely responsible for implementing and maintaining appropriate administrative, physical, and technical safeguards on its own systems, networks, and devices (including but not limited to computers, laptops, mobile phones, and tablets) in accordance with the Security Rule) to protect the Confidentiality, Integrity, and Availability of PHI accessed, stored, or transmitted through such devices.
- TERM AND TERMINATION
- Term. The term of this Agreement shall be effective as of the date Covered Entity first purchased the Services under this Agreement, and shall terminate when all PHI provided by Covered Entity to RXNT, or created or received by RXNT on behalf of Covered Entity, is returned to Covered Entity or destroyed, or if it is infeasible to return or destroy PHI, protections are extended to such information, in accordance with the termination provisions in this Section.
- Termination for Cause. In addition to any termination rights outlined in this Agreement, in the event of a material breach of this BA Agreement, the non-breaching party shall provide the breaching party with a written notice describing the breach and an opportunity to cure the breach. If the breaching party does not cure the breach or end the violation within 60 days, the non-breaching party may terminate this Agreement (including the BA Agreement) by providing 30 days' written notice of termination.
- Disposition of PHI upon Termination. Except as provided for in paragraph (d) of this Section VI, upon termination of this BA Agreement for any reason, RXNT shall return or destroy all PHI received from the Covered Entity, or created or received by RXNT on behalf of Covered Entity, and shall retain no copies of PHI. If RXNT is required by law to retain a copy of such information, RXNT will maintain PHI for the requisite period required by law, after which RXNT shall return or destroy Covered Entity’s PHI. This provision shall also apply to any PHI in the possession of RXNT’s Subcontractors. If it is infeasible for RXNT to return or destroy PHI upon termination of this BA Agreement, RXNT shall: (i) extend the protections of this Agreement to such PHI and (b) limit further uses and disclosures of such PHI to those purposes that make the return or destruction infeasible, for so long as the Business Associate maintains such PHI.
- Retention of Certain Information. Without limiting the generality of the foregoing, Covered Entity acknowledges and agrees that RXNT may determine that it is infeasible to return or destroy PHI if RXNT is required to retain PHI by applicable law or RXNT’s document retention policies. In addition, RXNT may delay the return or destruction of PHI until Covered Entity has confirmed in writing that Covered Entity has successfully exported or otherwise received PHI. Without limiting the generality of the foregoing, Covered Entity acknowledges and agrees that information generated through the use of the Services provided under this Agreement will be retained as necessary by the Business Associate for purposes of financial reporting, insurance claims, and other legal and business purposes beyond the term of this Agreement.
- Termination upon Change in Law. If the Secretary provides guidance changes and the relationship between the parties no longer constitutes a Business Associate relationship (“Regulatory Change”), either party may provide written notice to the other party of the Regulatory Change, and upon written mutual agreement between the parties that this Regulatory Change renders this Agreement unnecessary, this Agreement shall terminate and be null and void.
- Generally. Return, destruction, or, if infeasible, retention of PHI upon termination of this Agreement shall be governed by clauses (c) and (d) of this Section VI.
VII. MISCELLANEOUS
- Client Rights and Remedies Upon Breach By RXNT. In the event RXNT fails to perform its obligations hereunder or otherwise breaches this Agreement, Covered Entity may exercise all rights and remedies available to it under this Agreement, subject to applicable limitations of liability outlined in this Agreement or such other conditions as may apply to Covered Entity’s rights or remedies.
- Regulatory References. Any references in this Agreement to any law, rule, or regulation shall be interpreted to include the section as in current effect or as may from time to time be amended and for which compliance is required.
- Payment Processing. The Covered Entity acknowledges that this Agreement does not apply to payment processing services under HIPAA Section 1179, and a Business Associate Agreement is not required between RXNT and its Subcontractors that only provide products and services related to payment processing.
- Amendments. The parties agree to take such action as is necessary to amend this Agreement from time to time as is necessary for the Covered Entity and the Business Associate to comply with the requirements of the Privacy, Security, or Breach Notification Rules, as well as HIPAA and the HITECH Act; however, all amendments to any of the provisions contained herein shall be made in writing.
- Survival. The respective rights and obligations of the Business Associate under Section IV of this BA Agreement shall survive the termination of this Agreement.
- Entire Agreement. This Agreement is the entire agreement between the parties with regard to its subject matter and shall supersede any prior agreements.
- Notice. Any notices required or relating to this Agreement will be made via U.S. MAIL or express courier to such party’s address given below, and/or via electronic mail to the email address listed below, and/or facsimile to the facsimile number listed below (or associated with the Covered Entity’s RXNT account).
Business Associate:
Networking Technology, Inc.
Attn: Legal
1449 Whitehall Rd.
Annapolis, MD 21409
- Conflict. In the event of conflict between the terms and conditions of this BA Agreement and the terms and conditions of the other provisions of this Agreement, this BA Agreement shall control.
ATTACHMENT E - Privacy Policy
Your privacy is extremely important to RXNT. The RXNT Website and Client Services Privacy Policy found at https://www.rxnt.com/client-services-privacy-policy/ governs your use of the Services.
California Consumer Privacy Act of 2018
CCPA Definition
CCPA means the California Consumer Privacy Act of 2018, as amended (Cal. Civ. Code §§ 1798.100 to 1798.199.95), the CCPA Regulations (Cal. Code Regs. tit. 11, §§ 7000 to 7102), and any related regulations or guidance provided by the California Attorney General. For the purposes of this Section, terms defined in the CCPA, including personal information and business purposes, carry the same meaning.
a. Application of This Section
This Section applies solely to the extent that: (i) RXNT’s provision of the Service is not exempt from the CCPA under California Civil Code section 1798.145(c)(1)(A) and (c)(1)(B) pertaining to medical information, PHI, providers of healthcare, and covered entities; (ii) Customer is a “business” within the meaning of the CCPA; and (iii) RXNT is processing the personal information of California residents.
Customer personal information includes any “personal information” contained within the data that RXNT “processes” (as defined in the CCPA) in connection with performing the Service.
b. Compliance
RXNT is a service provider and will not collect, retain, use, disclose, or otherwise process Customer personal information for any purpose other than performing the Service, or as otherwise permitted by the CCPA. RXNT will limit Customer personal information collection, use, retention, and disclosure to activities reasonably necessary and proportionate to provide the Service or to achieve another compatible operational purpose.
RXNT will not collect, use, retain, disclose, sell, or otherwise make Customer personal information available for RXNT’s own commercial purposes or in a way that does not comply with the CCPA. RXNT may, however, use, publicize, or share with third parties such data that it creates or derives from its provision of the Services, that is anonymized and/or aggregated data that does not identify Customer, any consumer, or household. RXNT may use this data to improve RXNT’s products and services and for RXNT’s other lawful business purposes. Notwithstanding the foregoing, RXNT may, with Customer’s consent, share Customer contact information with certain partners we may work with.
RXNT must promptly comply with any Customer request or instruction requiring RXNT to provide, amend, transfer, or delete Customer personal information, or to stop, mitigate, or remedy any unauthorized processing unless otherwise permitted by the CCPA.
Customer and RXNT, notwithstanding anything in the Agreement entered into, acknowledge and agree that RXNT’s access to Customer personal information is not part of the consideration exchanged by the parties in respect of the Agreement.
If a law requires RXNT to disclose Customer personal information for a purpose unrelated to the Service, RXNT must first inform Customer of the legal requirement and give Customer an opportunity to object or challenge the requirement, unless the law prohibits such notice.
RXNT may use a subcontractor to provide or support the provision of the Service. Any subcontractor used must qualify as a service provider under the CCPA, and RXNT will not make any disclosures to the subcontractor that the CCPA would treat as a sale.
RXNT certifies that it understands its obligations under this paragraph and must comply with them.
c. Customer’s Responsibilities
Customer is solely responsible for: (i) identifying whether the CCPA applies to Customer; (ii) providing any notices of your privacy practices that may be required by CCPA; and (iii) identifying and responding to verifiable consumer requests to exercise CCPA (CCPA Rights Requests) rights to access, delete, or opt out of the sale of personal information, including for verifying the identity of consumers submitting CCPA Rights Requests and for evaluating the scope and legality of such requests. Customer is solely responsible and liable for responding to an individual's CCPA Rights Requests, including without limitation the content and timing of the response, in compliance with the CCPA.
The Customer may not direct or otherwise cause RXNT to share any Customer personal information with any third party in a manner that may constitute a “sale” as defined in the CCPA.
CPPA Rights Requests
RXNT will provide reasonable assistance to Customer in responding to such CCPA Rights Requests, including assistance in providing self-service functionality.
RXNT will treat any CCPA Rights Request that Customer submits under CCPA as presumptively valid under CCPA. With respect to CCPA Rights Requests for which Customer requires RXNT to assist, Customer must: (i) notify RXNT within five days of its receipt of the CCPA Rights Request by emailing [email protected]; and (ii) provide RXNT with the consumer’s email address or such other information that would permit RXNT to honor the request.
Within ten business days of RXNT’s receipt of a CCPA Request for Access to Customer personal information, RXNT will provide Customer with a file that contains the Customer personal information that RXNT maintains about the individual via a secure method of transfer if necessary. RXNT may withhold from such file any Customer personal information that the CCPA does not require to be provided in such response.
Except as otherwise required by applicable law or permitted by the CCPA, RXNT, within ten business days of receipt of a CCPA Request for Deletion of Customer personal information, will delete the Customer personal information, to the extent RXNT maintains such Customer personal information about the individual. RXNT may delete such Customer personal data by anonymizing and/or aggregating the information such that the information does not identify and is not reasonably capable of identifying the individual.
ATTACHMENT F - Security Notice
How We Protect Your Data on Our Web-based Software Services
What This Security Notice Covers
This security notice pertains to the security measures in place at RXNT for the protection of personal and protected health information in connection with the use of the RXNT website, and the RXNT PM (practice management), RXNT EHR (electronic health records), and RXNT ERX (electronic prescribing) web-based services (collectively, Service).
Unique identification of users
To comply with the HIPAA requirements and to provide a secure service, RXNT requires all users to have a unique username.
In addition to a username, every user account must be protected with a password of sufficient complexity. RXNT ERX service sign-ins are protected by account lockout for non-usage.
Security on the RXNT website
RXNT Service users may choose to sign into their account at the RXNT website. Such sign-ins are protected by SSL security. Your browser will usually display an indicator (such as a "lock" icon) when using a secure SSL connection.
Security in the RXNT service
The RXNT Service communicates with secure RXNT hosted and controlled servers and networks. All communications are secured with public-key encryption. RXNT disallows the use of low cipher strength in our production service.
RXNT helps to ensure physical and technical security protections of customer data, as it uses servers located in SOC 2 Type 2 certified hosting providers.
RXNT employs redundant, next-generation firewalls, intrusion detection, and prevention services monitored 24X7X365. RXNT uses a PCI Approved Scanning Vendor (ASV), internal and external threat prevention, delivering timely and accurate reports of our production services.
In addition to these controls, RXNT deploys Azure cloud defender and Azure cloud native protection services, which help to identify, block, and track hacking attempts, scans, data breaches, adware, malware, spyware, Trojans, phishing attempts, and other equally malicious requests.
RXNT ensures encryption of data at rest by implementing an Azure-provided cloud native solution.
Role-based security
Every user in the RXNT Service belongs to one or more roles. A role is defined by each customer and is assigned a set of permissions.
Application locking
In accordance with HIPAA policies, RXNT’s Service will automatically lock up if left unattended for a period of time. Correct credentials of the user will need to be provided prior to using the application again.
RXNT password policy
RXNT system passwords are meant to help protect sensitive patient medical and financial records, as well as practice financial information. They serve as a deterrent to malicious agents as well as protection against casual or accidental lowering of security through carelessness.
The passwords are encouraged to be at least eight (8) characters long and have to maintain a level of complexity such that they will not be easily guessed or cracked by a determined attacker. The passwords will expire regularly.
A user may change their password at any point in the RXNT website. Passwords changed by administrators/RXNT Support staff will immediately expire to allow users to log in, but also to ensure that they immediately change their passwords to something that only they know.
RXNT will never store any passwords in permanent storage in a way that is reversible. The RXNT Service will never show the password in plain-text, human-readable form.
Changes to this security policy
RXNT may update this policy at any time for any reason. If there are any significant changes to how we handle security, we will make a reasonable commercial effort to send a notice to the contact email address specified in your company's RXNT account or by placing a prominent notice on our site.
Questions?
If you have questions or suggestions, you can contact us at:
Thomas Kavukat, CTO
RXNT
1449 Whitehall Road
Annapolis, MD 21409
[email protected]
To report a security violation, please call us at 800-943-7968.
ATTACHMENT G - Data Return Policy FAQ
The following FAQ outlines RXNT’s policies for the return of data regarding RXNT services as referenced in the RXNT Terms of Service Agreements, Section 8.
This FAQ will be updated regularly to ensure regulatory compliance, allow adjustments for various changes in workflow, updated product features, and operational efficiency.
RXNT PM (Practice Management), RXNT EHR (electronic health records), and RXNT ERX (electronic prescribing).
Q: If I terminate my contract with RXNT, will I have an opportunity to download my data?
A: Customer can initiate or perform their own data export before the actual termination date at no cost. Once Customer terminates their contract, RXNT provides three data export options:
- The first is a standard data export, priced at $2,000.
- The second option is a premium data export, priced at $5,000. We will provide the Customer data in Comma Separated Values (.CSV) file format with certain PDFs with Index Files. Additional information regarding the data elements included in these exports can be found here: https://help.rxnt.com/hc/en-us/articles/4418221122839-Data-Export.
- The third option is Customer may purchase a read-only license and perform data export.
Q: What happens to my data after the actual termination date?
A: RXNT will continue to retain the Customer’s data for an additional minimum of 60 days (Data Retention Period) as a safeguard if the client requires additional data.
Q: If I discover that I need additional information during the Data Retention Period, how can I obtain the additional data?
A: Please contact the RXNT Support Department (Support) at [email protected] for assistance. Depending on the additional information sought, there may be additional fees.
Q: During the Data Retention Period, will RXNT continue to maintain the privacy, security, and integrity of my data as defined by HIPAA?
A: As noted in the RXNT Business Associate Agreement (BAA), RXNT will continue to extend the protections of the BAA agreement during the Data Retention Period.
Q: What data can I download from the system?
A: Customer can download certain information from RXNT EHR, Billing, and certain other solutions while Customer’s subscription is active for no additional cost.
Q: Will RXNT maintain a copy of my data to comply with local, state, federal, and/or HIPAA Medical Records retention mandate (6-10 years depending on the state)?
A: After the Data Retention Period is completed, RXNT will properly dispose of customer data containing PHI or otherwise continue to extend the protections as provided in the RXNT BAA. Customer will solely be responsible for complying with all state and HIPAA records retention requirements.
Q: Can I get a refund or credit if I cancel the Services?
A: No. As stated in the Pricing Policy, RXNT does not refund or credit subscription fees for partial months or for any portion of a prepaid plan upon a deactivation of a Provider or account cancellation.
ATTACHMENT H - Service Level FAQ
The following FAQ outlines RXNT’s service level agreement regarding RXNT services as referenced in the RXNT Terms of Service Agreements, Section 4, a.
This FAQ will be updated regularly to ensure regulatory compliance, allow adjustments for various changes in workflow, updated product features, and operational efficiency.
RXNT PM (Practice Management), RXNT EHR (electronic health records), and RXNT ERX (electronic prescribing).
Q: Does RXNT guarantee a system uptime and reliability?
A: RXNT makes every effort to maintain an uptime of 99%.
Q: Where are the RXNT data centers?
A: RXNT data centers are located in Texas.
Q: What redundancy is in place?
A: There is redundancy of all critical systems & network components
Q: Is there a disaster recovery plan?
A: Yes. RXNT’s data center has a fully functional disaster recovery plan in place.
Q: How does RXNT handle scheduled outages and maintenance?
A: RXNT may conduct maintenance online at any hour when a service interruption is not required. RXNT will make a reasonable effort to conduct scheduled system maintenance that requires an outage between the hours of 11:00 PM and 7:00 AM Eastern Time.
Last Updated: This document was last updated on July 1, 2025